
Reimbursement Is Neurotech's Biggest Risk with Juan-Pablo Mas
In this episode, your host, Liz Moyles, is joined by Juan-Pablo Mas, Managing Director at Action Potential VC to talk about investing at the frontier of neurotech and bioelectronic medicine, and why reimbursement, not te


























